go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

Tennessee rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $831,764 · 10th–90th $562,341$1,202,2640%20%10th90th$831,764Professionalmedian $562,341 · 10th–90th $562,341$616,5950%50%90th$562,341$100.0K$200.0K$500.0K$1.0M$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$831,763.77
Typical High
$1,230,268.77
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$602,559.59
BCBS
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$630,957.34
Cigna
Setting
Professional
Modifier
Global
Typical Low
$537,031.80
Median
$616,595.00
Typical High
$707,945.78
Lucent Health
Setting
Facility
Modifier
Global
Typical Low
$977,237.22
Median
$977,237.22
Typical High
$977,237.22
Lucent Health
Setting
Professional
Modifier
Global
Typical Low
$977,237.22
Median
$977,237.22
Typical High
$977,237.22
United
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$602,559.59
Typical High
$1,202,264.43
United
Setting
Professional
Modifier
Global
Typical Low
$426,579.52
Median
$562,341.33
Typical High
$645,654.23